Incidence patterns of STEMI and NSTEMI in type 1 diabetes depend on age, vascular history, and kidney function, a Finnish ...

Complete rather than culprit-only revascularization appears to pay off long-term for patients with multivessel disease presenting with non-ST-segment elevation MI (NSTEMI), suggests an observational ...

Among patients presenting to the hospital with NSTEMI, an early invasive strategy based on symptom-to-catheter time is associated with a lower risk of all-cause mortality at 3 years, according to new ...

NEW ORLEANS, LA — In a study of more than 9000 patients who were hospitalized for non-ST-segment-elevation MI (NSTEMI), those who received early revascularization (within 24 hours) were more likely to ...

Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...

The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most receiving PCI, according to an analysis presented this week at CRT 2026. But as ...

An invasive strategy vs. optimal medical therapy alone after a non-ST-elevation myocardial infarction (NSTEMI) in older adults did not affect the combined risk of cardiovascular death or MI, although ...

LONDON -- Routine coronary intervention was safe and somewhat beneficial for older people with non-ST-segment elevation myocardial infarction (NSTEMI) in the SENIOR-RITA trial, unique for being ...